Evidence-based guidelines for care are largely single-disease orientated, and not suitable for patients with multiple concurrent diseases. Drugs used for one condition can have adverse effects on other existing conditions – causing ADEs.
Inappropriate prescribing causes 22,300 deaths per year in the UK and is the 5th biggest killer. 52% of medicines related harm recorded was considered potentially preventable, costing the NHS £1billion per annum.
How it works
The Medication Review Solution works well beyond the capabilities of simple drug to drug interaction databases, according to the two most widely recognised prescribing criteria, StoppStartTM Criteria and AGS BeersTM Criteria. The technology considers a patient’s entire medical history, including medication list in combination with medical diagnosis list and biomedical readings to recommend discontinuing medications and/or reducing dosage which may be causing harm, or may no longer be providing benefit to the patient.
The software also identifies important potential prescribing omissions for the patient based on their current medical diagnosis.
Each patient medical record is reviewed instantly and automatically. Any changes made in the patient medical record, including added clinical information, are picked up by the software and the review is re-run to incorporate these changes.
Real-time alert recommendations are made at point of consultation and are not confined to point of prescribing, alerting the clinician immediately to a current medication treatment which is potentially inappropriate or a potential prescribing omission.
Analytics Platform
The Medication Review Solution analytics platform generates reports at both patient and population level. All patient medication reviews completed by the software are accessible through the analytics platform and are updated daily, ensuring all reports generated by clinicians and healthcare providers are always up-to-date.
Patient Level Reporting
- Clinicians have immediate access to each patient’s most recent medication review completed by the software.
- Provides a retrospective review of all alert recommendations for each patient and the subsequent actions taken by clinicians.
Population Level Reporting
- Identify patients triggering the highest number of alerts.
- Target patients at highest risk of ADEs, and identify changes needed in their drug therapy.
- View prescribing behavior and track changes and improvements over time.
- Identify drug savings opportunities.